In a Significant Percentage of Patients, Neoadjuvant Therapy Yields Equivalent Survival, With Better Quality of Life and Lower Costs
Anna Fagotti, MD, PhD
Advertisement
Articles by Anna Fagotti, MD, PhD
Advertisement
Latest Updated Articles
COUNTERPOINT: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian CancerPublished: June 15th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
JSKN003 Receives FDA Fast Track Designation in Advanced PROC
2
Belzutifan Plus Lenvatinib Improves PFS/ORR in Advanced Pretreated RCC
3
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
4
What Path to Approval Has Dasatinib Taken in CML/ALL?
5
